Molecules of Korolchuk IP-NFT VITA-FAST
Xếp hạng #8786
08:18:00 01/02/2024
Giá Molecules of Korolchuk IP-NFT (VITA-FAST)
$10.37 0%
0.0002462 BTC
267,461 VND
Thấp: $10.37
Cao: $10.37
Thông tin Molecules of Korolchuk IP-NFT (VITA-FAST)
| Trạng thái | Không theo dõi |
| Website | |
| Block Explorer | https://etherscan.io/token/0x6034e0d6999741f07cb6fb1162cbaa46a1d33d36 https://ethplorer.io/address/0x6034e0d6999741f07cb6fb1162cbaa46a1d33d36 |
| Nền tảng | |
| Ngày thêm vào danh sách | 20:07:25 20/11/2023 |
| Thẻ | Ethereum Ecosystem |
Số liệu thống kê Molecules of Korolchuk IP-NFT (VITA-FAST)
| Giá Molecules of Korolchuk IP-NFT (VITA-FAST) hôm nay | |
|---|---|
| Giá Molecules of Korolchuk IP-NFT (VITA-FAST) | $10.37 |
| Dao động 1 giờ | 0% |
| Dao động 24 giờ | 0% |
| Dao động 7 ngày | 0% |
| Giá Thấp / Cao nhất (24h) | / |
| Khối lượng giao dịch 24 giờ | - |
| Vốn hóa | - |
| Xếp hạng | #8786 |
| Giá Molecules of Korolchuk IP-NFT (VITA-FAST) hôm qua | |
| Giá Thấp / Cao nhất hôm qua | $10.37 / $10.37 |
| Giá Mở / Đóng hôm qua | $10.37 / $10.37 |
| Dao động giá hôm qua | -% |
| Khối lượng giao dịch hôm qua | |
| Nguồn cung Molecules of Korolchuk IP-NFT (VITA-FAST) | |
| Tổng VITA-FAST đang lưu hành | |
| Tổng cung | 1,000,000 VITA-FAST |
| Tổng cung tối đa | |
| Lịch sử giá Molecules of Korolchuk IP-NFT (VITA-FAST) | |
| Giá Thấp / Cao 7 ngày | / |
| Giá Thấp / Cao 30 ngày | / |
| Giá Thấp / Cao 90 ngày | / |
| Giá Thấp / Cao 52 tuần | / |
| Giá cao nhất lịch sử | |
| Giá thấp nhất lịch sử | |
VitaDAO, a decentralized autonomous organization, introduces VITA-FAST, an innovative funding model for longevity research. Leveraging the Ethereum blockchain, VITA-FAST are ERC-20 tokens, signifying fractional ownership of the Intellectual Property Non-Fungible Token (IP-NFT) from longevity research conducted at the Korolchuk Lab, Newcastle University. VITA-FAST token holders gain governance rights over the IP, democratizing the decision-making processes in scientific research.
1. What is the project about?
The project is focused on discovering and developing therapeutic compounds that can reactivate autophagy in Npc1 -/- cells. This involves screening bioactive and commercial small molecules in cell survival assays to identify potential autophagy activators that are not cytotoxic. The project uses advanced techniques like luciferase-p6 clearance and Halo-GFP-LC3 orthogonal assays for this purpose.
2. What makes your project unique?
The project's uniqueness lies in its approach to identifying novel compounds that can induce autophagy in NPC1 -/- cells, a crucial process for treating Niemann-Pick Type C disease. Unlike existing treatments, this project employs high-throughput screening methods and innovative assays to discover compounds with high chemical variability and no similarity to existing autophagy inducers, opening up possibilities for new iIP.
3. History of your project.
The project, led by Dr. Korolchuk and his team at Newcastle University, has progressed from generating data on thousands of compounds using advanced screening assays to identifying lead compounds with potential autophagic properties. It has evolved to include the synthesis of derivatives of these compounds and is now moving towards drug translation processes, including pharmacokinetics and scalability studies.
4. What’s next for your project?
The next steps involve screening third-generation compounds, conducting in vitro and in vivo models using patient